Literature DB >> 14997367

Optimization of parameters for semiempirical methods IV: extension of MNDO, AM1, and PM3 to more main group elements.

James J P Stewart1.   

Abstract

The NDDO semiempirical methods MNDO, AM1, and PM3 have been extended to all the remaining non-radioactive elements of the main group, excluding the noble gases. Most of the new elements are of Groups I and II. 44 sets of parameters are presented for the following methods and elements. MNDO: Na, Mg, K, Ca, Ga, As, Se, Rb, Sr, In, Sb, Te, Cs, Ba, Tl, and Bi; AM1: Li, Be, Na, Mg, K, Ca, Ga, As, Se, Rb, Sr, In, Sn, Sb, Te, Cs, Ba, Tl, Pb, and Bi; PM3: B, Na, K, Ca, Rb, Sr, Cs, and Ba. Average errors are presented for heats of formation, molecular geometries, etc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14997367     DOI: 10.1007/s00894-004-0183-z

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  37 in total

1.  electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation.

Authors:  Nigel W Moriarty; Ralf W Grosse-Kunstleve; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16

Review 2.  Semiempirical Quantum Mechanical Methods for Noncovalent Interactions for Chemical and Biochemical Applications.

Authors:  Anders S Christensen; Tomáš Kubař; Qiang Cui; Marcus Elstner
Journal:  Chem Rev       Date:  2016-04-13       Impact factor: 60.622

3.  EMPIRE: a highly parallel semiempirical molecular orbital program: 3: Born-Oppenheimer molecular dynamics.

Authors:  Johannes T Margraf; Matthias Hennemann; Timothy Clark
Journal:  J Mol Model       Date:  2020-02-03       Impact factor: 1.810

4.  Computational study of IR, Raman, and NMR spectra of 4-methylmethcathinone drug.

Authors:  Valentina Minaeva; Boris Minaev; Alexander Panchenko; Vyacheslav Pasychnik
Journal:  J Mol Model       Date:  2021-01-02       Impact factor: 1.810

5.  Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase.

Authors:  Bo Wen; Jed N Lampe; Arthur G Roberts; William M Atkins; A David Rodrigues; Sidney D Nelson
Journal:  Arch Biochem Biophys       Date:  2006-08-22       Impact factor: 4.013

6.  Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes.

Authors:  Tushar S Basu Baul; Anup Paul; Lorenzo Pellerito; Michelangelo Scopelliti; Palwinder Singh; Pooja Verma; Andrew Duthie; Dick de Vos; Edward R T Tiekink
Journal:  Invest New Drugs       Date:  2009-12-11       Impact factor: 3.850

7.  The cytotoxic potential of cationic triangulenes against tumour cells.

Authors:  Euphemia Leung; Lisa I Pilkington; Mohinder M Naiya; David Barker; Ayesha Zafar; Chatchakorn Eurtivong; Jóhannes Reynisson
Journal:  Medchemcomm       Date:  2019-08-21       Impact factor: 3.597

8.  Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements.

Authors:  James J P Stewart
Journal:  J Mol Model       Date:  2007-09-09       Impact factor: 1.810

9.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

10.  Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes.

Authors:  Tushar S Basu Baul; Anup Paul; Lorenzo Pellerito; Michelangelo Scopelliti; Palwinder Singh; Pooja Verma; Dick de Vos
Journal:  Invest New Drugs       Date:  2009-07-30       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.